Home
Company
Our Science
Pipeline
Newsroom
Investors

Company

Home

Company

Team

Committed to being at the forefront of cutting-edge research and innovation in the realm of oncology.

Instagram

X

Vimeo

Expanded Access Policy
Calidi Biotherapeutics does not currently have an expanded access program for our investigational product Supernova-1 (SNV1). Participation in our clinical trial is the only way to access SNV1 at this time.

Company

Home
Company
Our Science
Pipeline
Newsroom
Investors

Science

Our Science
Pipeline
How It Works
Novel Platform
Publications
Newsroom

General

Privacy Policy
Cookie Policy
DSARDo
Not Sell or Share My Information

Web Design by Appnet.com | Sitemap

Company

About

Team

Company

Science

General